Obesity is a disorder with a complex genetic etiology, and its epidemic is a worldwide problem. Although multiple genetic loci associated with body mass index, the most common measure of obesity, have been identified in European populations, few studies have focused on Asian populations. Here we report a genome-wide association study and replication studies with 62,245 east Asian subjects, which identified two new body mass index-associated loci in the CDKAL1 locus at 6p22 (rs2206734, P = 1.4 × 10 −11 ) and the KLF9 locus at 9q21 (rs11142387, P = 1.3 × 10 −9 ), as well as several previously reported loci (the SEC16B, BDNF, FTO, MC4R and GIPR loci, P < 5.0 × 10 −8 ). We subsequently performed gene-gene interaction analyses and identified an interaction (P = 2.0 × 10 −8 ) between a SNP in the KLF9 locus (rs11142387) and one in the MSTN (also known as GDF8) locus at 2q32 (rs13034723). These findings should provide useful insights into the etiology of obesity.
Obesity is a disorder with a complex genetic etiology, and its epidemic is a worldwide problem. Although multiple genetic loci associated with body mass index, the most common measure of obesity, have been identified in European populations, few studies have focused on Asian populations. Here we report a genome-wide association study and replication studies with 62,245 east Asian subjects, which identified two new body mass index-associated loci in the CDKAL1 locus at 6p22 (rs2206734, P = 1.4 × 10 −11 ) and the KLF9 locus at 9q21 (rs11142387, P = 1.3 × 10 −9 ), as well as several previously reported loci (the SEC16B, BDNF, FTO, MC4R and GIPR loci, P < 5.0 × 10 −8 ). We subsequently performed gene-gene interaction analyses and identified an interaction (P = 2.0 × 10 −8 ) between a SNP in the KLF9 locus (rs11142387) and one in the MSTN (also known as GDF8) locus at 2q32 (rs13034723). These findings should provide useful insights into the etiology of obesity.
Obesity is a major risk factor for a number of chronic diseases, and its recent rise in prevalence worldwide has imposed serious medical and economic burdens 1 . It is well known that obesity is a highly heritable trait, and around 40-70% of the inter-individual variation in obesity is attributable to genetic factors 2 . Recently, genome-wide association studies (GWAS) identified dozens of genetic loci associated with body mass index (BMI), the most common measure of obesity [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . However, most of these studies were conducted in European populations, and few studies have assessed Asian populations 5, 11 , which account for two-thirds of the world's population. The degree of adiposity and the risks of diseases exacerbated by obesity are greater in Asians than in Europeans when evaluated with the same BMI 13 . Thus, the study of Asian populations might lead to the identification of new obesityassociated loci and provide insight into the genetic architecture of obesity. We report here a large-scale GWAS and replication studies of BMI examining a total of 62,245 subjects from east Asian populations.
In the GWAS for BMI, we enrolled 26,620 Japanese subjects under the support of the BioBank Japan Project 14 (Supplementary Table 1 and Supplementary Fig. 1 ). We applied stringent quality control criteria, including principal component analysis (PCA) for evaluating potential population stratifications, as previously described 15 . To extend the coverage to the genomic region, we performed wholegenome imputation for SNPs, and we obtained the genotype data for 2,178,018 autosomal SNPs with minor allele frequency (MAF) ≥ 0.01. We evaluated each SNP for association with BMI using a linear regression model assuming additive effects of the allele dosages using the rank-based inverse-normal-transformed values of BMI. Although no significant population stratification was suggested in our study population (Supplementary Fig. 2 ) or in our previous studies of Japanese subjects 15 , for robustness, we applied genomiccontrol corrections to the results of the GWAS using a genomic control inflation factor (λ GC ) of 1.123 (referenced λ GC_1,000 = 1.005) 16 . The quantile-quantile plot of the resulting P values indicated a remarkable discrepancy in its tail from the null hypothesis ( Supplementary Fig. 3) , which suggested the presence of statistically significant associations in this GWAS. We identified significant associations in three chromosomal loci (the KLF9 locus at 9q21, the BDNF locus at 11p14 and the GIPR locus at 19q13) that satisfied the genome-wide significance threshold of P < 5.0 × 10 −8 ( Table 1 and Fig. 1a) . 16 To further validate the associations identified in the GWAS, we performed replication studies on three independent sets (Supplementary Table 1 and Supplementary Fig. 1 ). The first and second sets consisted of 3,763 and 4,147 Japanese subjects from the BioBank Japan Project 14 , respectively. The third set consisted of 27,715 subjects enrolled in the concurrently conducted meta-analysis of GWAS for BMI with cohorts of east Asians 17 . First, we evaluated the 36 SNPs most significantly associated in each of the loci having P < 5.0 × 10 −5 in the GWAS in the first replication set and then further evaluated 11 SNPs with P < 5.0 × 10 −5 in the combined study of the GWAS and replication set 1 in replication sets 2 and 3. Using the combined results of the GWAS and the replication studies, we identified a total of seven loci that satisfied the genome-wide significance threshold (P < 5.0 × 10 −8 ; Table 1 ), which included the three loci that originally satisfied this threshold in the GWAS. Among the seven identified loci, five were previously identified to be associated with BMI in Europeans (the SEC16B, BDNF, FTO, MC4R and GIPR loci at 1q25, 11p14, 16q12, 18p21 and 19q13, respectively) [3] [4] [5] [6] [7] [8] [9] 11, 12 . The associations at the remaining two loci (6p22 and 9q21) had not been previously reported, including in the large-scale study of Europeans 12 , and were new findings, to our knowledge. The landmark associated SNP at 6p22 (rs2206734, P = 1.4 × 10 −11 ; Fig. 1b) is located in the coding region of CDKAL1, the gene encoding cyclin-dependent kinase 5 (CDK5) regulatory subunit associated protein 1-like 1. The other associated SNP at 9q21 (rs11142387, P = 1.3 × 10 −9 ; Fig. 1c) is located in the promoter region of KLF9, the gene encoding Krüppel-like factor 9 (also known as basic transcription element-binding protein 1, or BTEB1). The linkage disequilibrium block that includes rs11142387 also covers several genes, including MAMDC2, SMC5 and TRPM3 (Fig. 1c) . Although we examined tag copy number variants and performed an expression analysis of rs11142387 in the locus using a publicly available database, no significant findings were observed ( Supplementary Fig. 4 ). Our study showed suggestive associations (5.0 × 10 −8 ≤ P < 5.0 × 10 −5 ) in the CCK (encoding cholecystokinin) locus at 3p22 (rs4377469, P = 1.6 × 10 −7 ) and in the ZNF169 (encoding zinc finger protein 169) locus at 9q22 (rs10993160, P = 5.5 × 10 −7 ). The combination of these seven identified loci (P < 5.0 × 10 −8 ) explained 0.72% of the inter-individual variance in BMI; the FTO locus explained the largest proportion of the inter-individual variance in BMI (0.20%; Table 1 ).
To evaluate ethnic differences in the genetics of obesity, we further evaluated the associations of the loci with confirmed or suggestive associations (P < 5.0 × 10 −5 ) in the east Asian studies in Europeans using the results of a meta-analysis for 123,865 subjects performed by the GIANT consortium ( Table 1) 12 . We found the same directional effects of the alleles in this European population as we found in the east Asian population at all of the nine evaluated loci. We observed significant associations in five loci (P < 0.028, false discovery rate (FDR) < 0.05), including the CDKAL1 locus (P = 0.0049), but we saw no association in the KLF9 locus (P = 0.50) in the European population. Using our data, we then evaluated the associations of the previously reported BMI-associated loci, most of which had been identified in Europeans (Supplementary Table 2 ) [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 18 . Our study replicated the associations with the same directional effects of the alleles as the previous studies at ten loci, including the TMEM18, DNAJC27 (also known as RBJ)-ADCY3-POMC, GNPDA2, POC5 (also known as FLJ35779)-HMGCR, TFAP2B, TRHR, MTCH2, MAP2K5-SKOR1 (also known as LBXCOR1), SH2B1-ATP2A1 and BMP2 loci, in addition to the five loci that were already replicated in our GWAS (P < 0.02, FDR < 0.05). In regards to loci previously reported in Koreans 11 , we replicated the Referenced using the results of the genome-wide meta-analysis for BMI in European populations 12 . l e t t e r S reported association in FTO but not LOC729076 at 6q24 (Supplementary Table 2) .
Because obesity is a polygenic trait and epistasis may help dissect its genetic background 19 , we performed a gene-gene interaction analysis of BMI. We evaluated gene-gene interactions assuming additive × additive effects of SNPs 20 between each of the seven SNPs confirmed to be associated with BMI and all of the 2,178,018 genome-wide SNPs (Supplementary Fig. 5 ) using the subjects enrolled in the GWAS, and we then conducted a replication study. We found an interaction that satisfied the significance threshold (P < 5.0 × 10 −8 ) between rs11142387 at KLF9 and a SNP located in the promoter region of MSTN (myostatin, also known as growth and differentiation factor-8 or GDF8) at 2q32 (rs13034723, P = 2.0 × 10 −8 ; Table 2 and Fig. 2a) . Notably, the association of rs13034723 at the MSTN locus with BMI was not significant (P = 0.56; Supplementary Table 3) . When we stratified the association of rs11142387 by the genotypes of rs13034723, we observed a significant association of rs11142387 with BMI in the subjects with the AA genotype at rs13034723 (P = 8.7 × 10 −15 ; Supplementary Tables 4 and 5 and Fig. 2b ), although we observed no significant association at this SNP for the subjects with the AG or GG genotype (P = 0.0029 and P = 0.30, respectively).
Through the GWAS and the replication studies, we identified two new loci, in CDKAL1 and KLF9, associated with BMI in east Asians. These two loci also had significant associations with the risk of obesity (BMI ≥ 27.5; P = 1.1 × 10 −5 for CDKAL1 and P = 4.2 × 10 −4 for KLF9; Supplementary Table 6 ). The association in the CDKAL1 locus, but not the KLF9 locus, was shared between east Asians and Europeans 12 . Because the study in Europeans 12 had enough power to detect the KLF9 locus (>99%), under the assumption that this locus has the same effect size in Europeans as east Asians and given the allele frequency in Europeans (0.51), these results suggest that there exists ethnic heterogeneity in the effect of the KLF9 locus for BMI. We also performed a gene-gene interaction analysis and showed an interaction between the KLF9 and MSTN loci. Although the substantial role of epistasis in polygenic traits has been recognized, the approach to elucidate actual epistatic associations has been challenging 20 . Our findings are one of the first pieces of evidence for the presence of epistatic associations.
Recent studies reported associations of the CDKAL1 locus with BMI at an age of 8 years (rs4712526) 21 and with birthweight (rs7756992) 22 , and these two SNPs also had significant associations in our GWAS (P < 5.0 × 10 −5 ). To our knowledge, our study is the first to report on the association with adult BMI. The CDKAL1 locus has been reported to be a risk locus for type 2 diabetes (T2D) 23, 24 . We found that the T allele of rs2206734, which was associated with a lower BMI, significantly increased T2D risk in our study subjects (P < 1.4 × 10 −18 ; Supplementary Table 6 ). CDKAL1 risk variants for T2D were previously associated with decreased insulin secretion 23 ; therefore, the observed effects of the CDKAL1 risk variant on lower BMI might be mediated by decreased insulin secretion. Notably, a recent study identified similar patterns of associations in the GIPR locus 25 , and we observed that the A allele of rs11671664 at GIPR, which is also associated with lower BMI, increased T2D risk (P < 1.5 × 10 −5 ; Supplementary Table 6 Fig. 1 ). d The allele dosage of allele 1 was used as an independent variable. e The product of the allele dosages of allele 1 of rs11142387 and allele 1 of rs13034723 was used as the independent variable. l e t t e r S that comprehensively assess genetic associations with T2D risk, BMI and insulin secretion should be performed. When we excluded the subjects affected with T2D (n = 12,234), the association of rs2206734 with BMI was not obvious (effect size = 0.031, P = 1.4 × 10 −6 ). We evaluated the association of the CDKAL1 and GIPR loci with other related traits, including systolic and diastolic blood pressure and serum lipid levels (total cholesterol, high-density-lipoprotein cholesterol, low-density-lipoprotein cholesterol and triglycerides), however, we observed no significant associations with any of these traits (α = 0.05; Supplementary Table 6) . KLF9 is a member of zinc-finger transcription factors involved in various physiological processes. A recent study indicated KLF9 as a pro-adipogenic transcription factor acting through the transactivation of PPARγ 26 , a key component of adipocyte differentiation that has been implicated in obesity 27 . Researchers from a previous study 18 reported the association of the KLF7 locus with obesity in the Danish population, although we could not test the relevance of this locus here because the SNP reported in that study, rs7568369, is not polymorphic (Supplementary Table 2) . It is known that KLF5, a gene belonging to the KLF family and also known as BTEB2, regulates adipocyte differentiation 28 . Considering these observations, the association of the KLF9 locus with BMI would be plausible from a biological aspect. Contrary to the results from the CDKAL1 locus, we observed no significant associations of KLF9 with T2D risk or with other related traits (α = 0.05; Supplementary Table 6) .
MSTN encodes a member of the transforming growth factor-β (TGF-β) superfamily that regulates mesenchymal stem cell proliferation 29 . A loss-of-function mutation in MSTN causes muscle hypertrophy and decreased body fat 29, 30 . In our study, the SNP in the MSTN locus was not associated with BMI, but its genotypes clearly stratified the association in the KLF9 locus. This would imply a regulatory role of MSTN on the effect of KLF9 on BMI, and further studies evaluating functional epistasis should be performed. Notably, researchers from a previous study 31 identified similar conserved promoter and enhancer architecture in KLF9 and MSTN through a search of evolutionary conserved regions, which suggests that these two genes may form a synexpression group 31 . Other genes located near MSTN, such as C2orf88, could also be candidates, and the relatively small sample size used in the replication studies provided limited evidence of this.
Researchers at concurrent study 17 have reported a genome-wide meta-analysis for BMI using data of eight cohorts of east Asians. The subjects enrolled in these two studies overlapped because of their reciprocal replication approaches, and newly identified loci were shared at CDKAL1, whereas some loci were specifically identified in each study, such as KLF9. These differences could be attributed to differences in study designs, effects of different compositions of the populations in the discovery phases and the probability of studyspecific bias induced by the winner's curse effect.
In summary, our study identified new associations of the CDKAL1 and KLF9 loci with BMI in east Asians. We also found a gene-gene interaction between the KLF9 and MSTN loci. Our study should contribute to understanding of the genetic architecture of obesity.
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Subjects. The subjects enrolled in the GWAS (n = 26,620) and replication sets 1 and 2 (n = 3,763 and n = 4,147, respectively) were obtained from the BioBank Japan Project 14 at the Institute of Medical Science, the University of Tokyo, which consisted of subjects with 1 of 32 diseases (Supplementary Table 1 ). Subjects with ages <18 or >85 years, subjects who had undergone dialysis treatment or subjects who were determined to be of non-Japanese origin by self-report or by PCA in the GWAS or our previous study 15 were not included. Clinical information on the subjects including age (61.3 ± 12.9 years (mean ± s.d.)), gender (47.2% female) and smoking history (49.8% 'eversmoker') were collected by a standard questionnaire. BMI values (22.7 ± 3.59 (mean ± s.d.)) were calculated based on self-reported height and weight. BMI based on self-reported data is known to be highly correlated (r > 0.94) with that based on measurements 32 , and any potential bias induced by self-reported data may have little impact on the analyses 32,33 . All participants provided written informed consent as approved by the ethical committees of the RIKEN Yokohama Institute and the Institute of Medical Science, University of Tokyo. The subjects enrolled in the replication set 3 (n = 27,715) consisted of subjects from the eight cohorts of east Asian populations, and these subjects were enrolled in the discovery stage of the concurrent meta-analysis for BMI 17 .
The subjects in our GWAS were also enrolled in the replication stage of the meta-analysis 17 .
Genotyping and quality control. We used the data from 32 GWAS performed for the BioBank Japan Project, in which subjects with each of the 32 diseases were genotyped (Supplementary Table 1) 14 . In the GWAS, genotyping was performed using the Illumina HumanHap610-Quad Genotyping BeadChip.
After excluding the subjects with call rates <0.98, we excluded SNPs with call rates <0.99, SNPs with ambiguous calls and non-autosomal SNPs. We excluded subjects in close kinships based on estimations using identity by state. We considered the subject pairs with an average proportion of alleles shared by identity by state >1.7 to be in first-or second-degree kinship and excluded the member of the pair with the lower call rates. We also excluded subjects whose ancestries were estimated to be distinct from the other subjects using PCA performed using EIGENSTRAT version 2.0. We performed PCA for the genotype data from our study along with the genotype data of unrelated European (CEU), African (YRU) and east Asian (Japanese and Han Chinese (JPT + CHB)) individuals obtained from the Phase II HapMap database (release 24) 34 . Based on the PCA plot, we excluded the outliers in regard to ancestry from the JPT + CHB clusters (Supplementary Fig. 1 ). We then excluded the SNPs with MAF < 0.01 or the SNPs with an exact Hardy-Weinberg equilibrium P < 1.0 × 10 −7 and obtained genotype data for 480,103 SNPs in 26,620 subjects. Genotype imputation was performed using MACH 1.0 in a two-step procedure. The individuals from the JPT and CHB populations obtained from the Phase II HapMap database (release 24) 34 were used as references. In the first step, recombination and error-rate maps were estimated using 500 subjects randomly selected from the GWAS data. In the second step, genotype imputation of all subjects was conducted using the rate maps estimated in the first step. We excluded the imputed SNPs with MAF < 0.01 or Rsq < 0.7 and obtained genotype data for 2,178,018 SNPs.
In the replication study sets 1 and 2, we used genotyping data that we obtained using the Illumina HumanHap550v3 Genotyping BeadChip and the Illumina HumanOmniExpress Genotyping BeadChip, respectively. We applied the same quality control criteria and imputation procedure as was used for the GWAS data. Details of the genotyping, quality control and imputation procedure used in replication set 3 are described elsewhere 17 .
Statistical analyses. Genome-wide association study and the replication studies of BMI. A rank-based inverse-normal transformation was applied to the BMI values of the subjects. In the GWAS, associations of the SNPs with transformed values of BMI were assessed by linear regression assuming additive effects of allele dosages (bound between 0.0 and 2.0) using mach2qtl software, and a genomic-control correction was applied 35 . In the regression model, gender, age, age-squared, smoking history, the affection statuses of the diseases and the demographic classifications of the medical institutes in Japan where the subjects were enrolled 36 were used as covariates. For the loci that satisfied P < 5.0 × 10 −5 in the GWAS, replication studies were conducted that consisted of three replication sets (Supplementary Table 1 and Supplementary Fig. 1 ). In replication sets 1 and 2, the associations of the SNPs were assessed in the same manner as they were in the GWAS. In replication set 3, we referred to the results from the discovery stage of the concurrently conducted genomewide meta-analysis of BMI 17 . The combined results of the studies were obtained using an inverse-variance method from the summary statistics β and the standard error (SE). Details of our examination of the tag copy number variants and our expression analysis of the KLF9 locus using publicly available database for HapMap Phase II east Asian individuals 34,37 are described in Supplementary Figure 4 . Associations of the SNPs that satisfied P < 5.0 × 10 −5 in the combined study of the GWAS and the replication studies were further evaluated using the results of the meta-analysis for BMI in European populations by the GIANT consortium 12 . For the evaluation of the associations in the previously reported BMI-associated loci [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 18 , the loci that had FDR < 0.05 based on the number of loci reported with non-monomorphic SNPs were considered to be significant. The statistical power of the study was estimated using Quanto version 1.2.4.
The inter-individual variance in BMI explained by each of the identified loci (P < 5.0 × 10 −8 in the combined study) was estimated using 2f(1 -f)β 2 , where f is the frequency of the variant in the HapMap east Asian populations and β is its additive effect size on the BMI obtained from the replication studies. To estimate the variance explained by the combination of the identified loci, we calculated the genetic risk scores for the subjects in the GWAS by summing the dosages of the alleles associated with higher BMI carried by the subjects weighted by the effect sizes of the SNPs obtained from the replication studies. The explained variance was estimated from a linear regression model incorporating this score as the predictor and the covariate-adjusted inverse normal transformed BMI residuals as the outcome.
Gene-gene interaction analysis of BMI.
The gene-gene interactions of the SNPs were evaluated using a multivariate linear regression model assuming additive × additive effects of two SNPs 20 . The allele dosages of the respective SNPs and the product of the allele dosages were included in the model, in addition to the covariates. The product of the allele dosages was considered an interaction term. For each of the landmark SNPs in the loci confirmed to be associated with BMI, the gene-gene interactions were evaluated with all of the genome-wide SNPs (7 × 2,178,018 SNP pairs; Supplementary  Fig. 5) , and genomic-control corrections were applied 35 . For SNP pairs that had P < 5.0 × 10 −6 for the interaction term, replication studies using replication sets 1 and 2 were performed. The SNP pair that satisfied P < 5.0 × 10 −8 in the combined study of the GWAS and the replication studies was considered to be significant.
Association study of metabolic and other related traits. Associations with obesity (BMI ≥ 27.5 (ref. 38); 3,058 cases and 31,472 controls), T2D (6,526 cases and 22,689 controls), systolic and diastolic blood pressure (n = 13,049), total cholesterol (n = 12,565), high-density-lipoprotein cholesterol (n = 4,924), lowdensity-lipoprotein cholesterol (n = 4,219) and triglyceride (n = 9,747) were evaluated using the subjects enrolled in the GWAS and in replication sets 1 and 2 (Supplementary Table 6 ). In addition to the two new loci associated with BMI (CDKAL1 and KLF9), we assessed the GIPR locus, where associations with T2D and its related traits have been reported 25 . A case-control analysis and analyses of the quantitative traits were performed using logistic and linear regression models, respectively, that included the covariates. In the association analysis of T2D, subjects not affected with cardiovascular diseases were enrolled as controls, and BMI was additionally incorporated as a covariate.
R statistical software was used for the general analysis. Details of the study design are also included in Supplementary Figure 1 
